Cargando…
Therapy group following a Ketamine treatment – a case report of a patient with resistant depression
INTRODUCTION: There are some patients that remain resistant to treatment for major depressive disorder - who were treated with two or more different medications, and did not demonstrate any improvement in their mental-state. These patients can be treated with a new treatment – Esketamine. The recomm...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568088/ http://dx.doi.org/10.1192/j.eurpsy.2022.1442 |
_version_ | 1784809561360695296 |
---|---|
author | Yaniv, H. Savlev, V. |
author_facet | Yaniv, H. Savlev, V. |
author_sort | Yaniv, H. |
collection | PubMed |
description | INTRODUCTION: There are some patients that remain resistant to treatment for major depressive disorder - who were treated with two or more different medications, and did not demonstrate any improvement in their mental-state. These patients can be treated with a new treatment – Esketamine. The recommended Esketamine treatment protocol includes 8-treatment sessions, each session lasts about two hours. In our clinic, we added a therapy group after each treatment. The therapy group is led by two co-therapist and lasts 30 minutes. The patients are invited to share their experiences from the session. OBJECTIVES: We will present a case report of a 44 year old man, that suffers from a major-depression for years, with symptoms such as loss of energy, recurrent thoughts of death and a decrease in functioning. He was treated with different medications, but there was no improvement in his mental state. METHODS: For the last six months, he was treated with Esketamine and also participated in the therapy group. RESULTS: According to content that he raised in the sessions of the therapy group and following conversations with him and with his close environment, we observed a clinical improvement in his condition – a positive mood, a decrease of the thoughts of death, an increase in his function at work and at home. CONCLUSIONS: He reported that the improvement is more significant because of the therapy group – he found a peer group, a place to process his treatment experience and to share his feelings and thoughts. We will present vignettes to demonstrate. DISCLOSURE: No significant relationships. |
format | Online Article Text |
id | pubmed-9568088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95680882022-10-17 Therapy group following a Ketamine treatment – a case report of a patient with resistant depression Yaniv, H. Savlev, V. Eur Psychiatry Abstract INTRODUCTION: There are some patients that remain resistant to treatment for major depressive disorder - who were treated with two or more different medications, and did not demonstrate any improvement in their mental-state. These patients can be treated with a new treatment – Esketamine. The recommended Esketamine treatment protocol includes 8-treatment sessions, each session lasts about two hours. In our clinic, we added a therapy group after each treatment. The therapy group is led by two co-therapist and lasts 30 minutes. The patients are invited to share their experiences from the session. OBJECTIVES: We will present a case report of a 44 year old man, that suffers from a major-depression for years, with symptoms such as loss of energy, recurrent thoughts of death and a decrease in functioning. He was treated with different medications, but there was no improvement in his mental state. METHODS: For the last six months, he was treated with Esketamine and also participated in the therapy group. RESULTS: According to content that he raised in the sessions of the therapy group and following conversations with him and with his close environment, we observed a clinical improvement in his condition – a positive mood, a decrease of the thoughts of death, an increase in his function at work and at home. CONCLUSIONS: He reported that the improvement is more significant because of the therapy group – he found a peer group, a place to process his treatment experience and to share his feelings and thoughts. We will present vignettes to demonstrate. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9568088/ http://dx.doi.org/10.1192/j.eurpsy.2022.1442 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Yaniv, H. Savlev, V. Therapy group following a Ketamine treatment – a case report of a patient with resistant depression |
title | Therapy group following a Ketamine treatment – a case report of a patient with resistant depression |
title_full | Therapy group following a Ketamine treatment – a case report of a patient with resistant depression |
title_fullStr | Therapy group following a Ketamine treatment – a case report of a patient with resistant depression |
title_full_unstemmed | Therapy group following a Ketamine treatment – a case report of a patient with resistant depression |
title_short | Therapy group following a Ketamine treatment – a case report of a patient with resistant depression |
title_sort | therapy group following a ketamine treatment – a case report of a patient with resistant depression |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568088/ http://dx.doi.org/10.1192/j.eurpsy.2022.1442 |
work_keys_str_mv | AT yanivh therapygroupfollowingaketaminetreatmentacasereportofapatientwithresistantdepression AT savlevv therapygroupfollowingaketaminetreatmentacasereportofapatientwithresistantdepression |